Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Cowen Reiterates Outperform Rating on Johnson & Johnson (JNJ) Following Q2 EPS
-
Novavax's COVID-19 Vaccine Wins FDA AdCom Blessing, Removing 'Major Overhang'
-
Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
-
Johnson & Johnson (JNJ) Reports 'Mixed' FQ1 Results and Guidance, Analysts Optimsitic
-
Reactions to J&J's plans to split into two companies
-
'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
-
Johnson & Johnson (JNJ) Pharma Strength and Medical Device Upside Create Attractive Setup - Cowen
-
Johnson & Johnson (JNJ) Fundamentals Look Strong into 2020 - Cowen
-
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
-
Johnson & Johnson (JNJ) Approval Could Be A Blockbuster - Cowen
-
Johnson & Johnson (JNJ) Talc-Related Risk Much Less Than Market Thinks - Cowen
-
J&J (JNJ) Shares Are Likely Oversold, Says Cowen
-
Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale
-
Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference
-
J&J/Animas (JNJ) Pump Exit Positive for Medtronic (MDT), Insulet (PODD), and Tandem Diabetes (TNDM) - Cowen
-
Cowen Reiterates Outperform Rating & $143 PT on Johnson & Johnson (JNJ); 'Invokana's Portrait Gets Prettier On A Positive CANVAS'
-
Johnson & Johnson (JNJ): Raising PT On Line Extensions -Cowen
-
With businesses split on U.S. border tax, wider reform looks shaky
-
Streetinsider.com's Hot Lunchtime Reads 10/22: (JNJ) (BIIB) (OCN) (FL) (RGLS)
-
Notable Analyst Rating Changes 04/14: (MA) (SCHW) (YHOO) Upgraded; (CRUS) (MSFT) (JNJ) Downgraded
-
Medivation (MDVN) Reverses after Cowen Research Called into Question by Janney
-
Notable Analyst Rating Changes 09/11: (BMY) (SYNC) (JAZZ) Upgraded; (SIRI) (TIBX) (GNOM) Downgraded
-
VIVUS (VVUS) Could Be Bought For Up to $40/Share
-
After-Hours Movers 12/29: (LNG) Higher; (AMR) (FPP) (SMA) (DCTH) Lower
-
MELA Sciences (MELA) Makes Several Key Board Appointees
-
Notable Analyst Rating Changes 10/04: (AMR) (SODA) (PLCM) Upgraded; (MDR) (GMR) (GTIV) Downgraded
-
Cowen Starts Johnson & Johnson (JNJ) at Outperform
-
Notable Analyst Rating Changes 05/25: (HAL) (BSX) (AVGO) Upgraded; (JNPR) (SAPE) (NETL) Downgraded
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Notable Analyst Rating Changes 02/01: VLO, AMD, HOLX, FMCN Higher; CHK, JNJ, HK, OREX Lower
-
Notable Analyst Rating Changes 12/09: GT, FMCN, HD, JNS Upgraded; LOW, JNJ, CS, GSIC Downgraded
-
Notable Analyst Rating Changes 3/20: MRK, JAS, JNJ Upgraded; JCG, URBN, AN Downgraded
-
Morning Movers: Xerox (XRX) Lower On Profit Warning, Dry Bulk Shippers Lower On Downgrade (ESEA, EGLE, DSX)
-
David Moenning's Daily State of the Markets: 3/20
-
Notable Analyst Rating Changes 10/29: BIIB, MTH, PCU Upgraded; JNJ, SWIR, ULTI Downgraded